ClinConnect ClinConnect Logo
Search / Trial NCT03688295

The Value of Post-operative Antibiotic Therapy After Laparoscopic Appendectomy for Complicated Acute Appendicitis (Other Than for Generalized Peritonitis)

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Sep 27, 2018

Trial Information

Current as of June 30, 2025

Recruiting

Keywords

Complicated Acute Appendicitis Post Operative Antibiotic Therapy

ClinConnect Summary

This clinical trial is studying whether patients who undergo laparoscopic appendectomy for complicated acute appendicitis really need to take antibiotics after their surgery. Complicated appendicitis can involve issues like a perforated appendix or abscesses, and traditionally, patients have been given antibiotics for a few days after the operation to prevent infections. However, recent studies suggest that this may not be necessary, and the trial aims to compare two groups: one that receives antibiotics for three days after surgery and another that receives a placebo, which is a harmless substance with no medication.

To participate in this trial, individuals must be 18 years or older and have been diagnosed with complicated acute appendicitis. They should also be able to provide written consent to join the study. Participants can expect to be monitored for a month after their surgery to see if there are any differences in infection rates between the two groups. It's important to note that specific health conditions, such as severe infections or certain allergies, may prevent someone from joining the study. This trial could help determine whether continuing antibiotics after surgery is truly beneficial for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. CAA suspected pre-operatively through a Saint-Antoine score ≤3 and confirmed peroperatively by the presence of a perforated appendicitis, extraluminal fecaliths, abscesses and/or localized peritonitis (pus in one or two abdominal quadrants).
  • 2. Laparoscopic appendectomy.
  • 3. Aged 18 or over
  • 4. Written, informed consent
  • Exclusion Criteria:
  • 1. Pre-operative exclusion criteria:
  • Patients with cardiac valvulopathy
  • Immunodepressed patients
  • Diabetic patients
  • Patients who have received an antibiotic treatment within 3 months before the surgery (and having a potential impact on the intestinal flora)
  • Related to the diagnosis: other diseases (Crohn's disease, ulcerative colitis, treatment with an immunosuppressive therapy).
  • * Related to the severity of the appendicitis:
  • A Saint-Antoine score of 4 or 5 (non-complicated acute appendicitis)
  • Severe sepsis, septic shock, generalized peritonitis
  • * Related to the treatment:
  • A decision to perform open appendectomy.
  • Patients who received an adaptive dose of Levofloxacine 250 mg/24H instead of 500 mg/24H in pre-operative or in per-operative (notably for patients with creatinine clearance ≤ 50 ml/min)
  • allergy to metronidazole or to one of the excipient
  • Contra-indication to the use of ceftriaxone (hypersensibility to the active substance, to another cephalosporin, to the excipient of the used speciality), history of severe hypersesibility (as anaphylactic shock), history of hypersensibility to another antibiotic of the beta-lactamin family (penicillin, monobactam, carbapénèmes)
  • Contra-indication to the use of levofloxacin, hypersensibility to levofloxacin, to another quinolone or to the excipient of one of the use speciality, hypersensibility to levofloxacine ou any other quinolone or to any excipient, epilepsia, history of tendinitis when injection of fluoroquinolones.
  • Related to the patient
  • Living at more than one hour from an hospital
  • Patient who has no relative or other third person who could be present at home and provide assistance in case of any problem for the discharged patient
  • 2. Per-operative exclusion criteria (related to the severity of appendicitis):
  • Non-complicated forms (catarrhal appendicitis or the absence of extraluminal fecaliths, abscess or peritonitis).
  • Generalized purulent or stercoral peritonitis (the presence of pus or faeces in more than two quadrants of the abdomen).
  • In order to assess the reproducibility of the inclusion criteria in the various centres and to avoid variations due to the lack of an official definition for localized peritonitis, all centres will receive a video tutorial on localized peritonitis before the start of the study.
  • Pregnancy or breastfeeding.
  • Patients under guardianship.
  • Patients unable to provide informed consent.
  • Patient lacking social security coverage
  • Allergy to metronidazole

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials